Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC (MIRACLE)
Primary Purpose
Ulcerative Colitis
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Multi-interventional program
Sponsored by
About this trial
This is an interventional prevention trial for Ulcerative Colitis focused on measuring ileoanal pouch, IPAA, pouch, ulcerative colitis, leak
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of Ulcerative Colitis
- Diagnosis of Crohn's disease limited to the colon without any history of perianal disease
- Modified two or three stage restorative proctocolectomy
- Age above 18
- Able to fill in questionnaires in local language and to come to out-patient-clinic visits;
Exclusion Criteria:
- Known allergy to ICG, or iodide allergy.
- Pregnancy
- Redo pouch operation
- Age under 18
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Other
Arm Label
Historic cohort
Multi-interventional program cohort
Arm Description
Outcomes
Primary Outcome Measures
Leak rate
Anastomotic integrity at one year postoperatively defined as the absence of presacral collections, anastomotic fistula and severe anastomotic stricture (not amenable for digital dilatation by rectal exam).
Secondary Outcome Measures
Cumulative anastomotic dehiscence rate
Anastomotic insufficiency at 30 days, 6 months and 12 months defined as contrast extravasation and/or presacral perianastomotic fluid collections on CT scan or Anastomotic dehiscence at endoscopy.
QOL
Quality of life and functional outcomes preoperatively and then 3, 6, 12 and 18 months post-operatively.
Protocol compliance
Protocol compliance to any intervention
ICG
Change in management due to ICG
CRP
Diagnostic accuracy of CRP for anastomotic leakage
EVAC
Efficacy of EVAC with early transanal closure of the anastomotic defect
Stoma rate
Permanent stoma rate at 18 months
Temporary ileostomy rate and duration
Temporary stoma rate and stoma duration at 18 months
Complications
Operative and post-operative complications within 30 days and 12 months (cumulative) of operation (using the Clavien-Dindo classification of surgical complications)
Death
Death
Hospital stay
Hospital stay and total hospital stay at one year
Reintervention rate
Reintervention rate
Readmission
Overall and stoma-related readmission
Cost analysis of EVAC
Cost analysis of anastomotic leakage and EVAC therapy
Full Information
NCT ID
NCT04939025
First Posted
June 23, 2021
Last Updated
June 23, 2021
Sponsor
London North West Healthcare NHS Trust
1. Study Identification
Unique Protocol Identification Number
NCT04939025
Brief Title
Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC
Acronym
MIRACLE
Official Title
Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC
Study Type
Interventional
2. Study Status
Record Verification Date
June 2021
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 1, 2021 (Anticipated)
Primary Completion Date
July 1, 2022 (Anticipated)
Study Completion Date
August 1, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
London North West Healthcare NHS Trust
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The objective of this quality improvement project is to increase the one year anastomotic integrity rate in patients having had completion proctectomy and pouch reconstruction for Ulcerative Colitis by the routine and quality controlled implementation of a multi-interventional program thereby improving long-term pouch function and survival.
Detailed Description
Ulcerative colitis is an inflammatory bowel disorder that affects predominantly young patients interfering with their social, family and professional life's (Ungaro, Mehandru, Allen, Peyrin-Biroulet, & Colombel, 2017). When the disease is moderate to severe, it is difficult to control medically even in the era of the biologic treatment. Colectomy rates are reported to be as high as 50% after 5 years in patients admitted with a severe exacerbation (Duijvis et al., 2016; Thorne et al., 2016). In a modified two (colectomy first followed by completion proctectomy and pouch) or three stage procedure (colectomy first followed by completion proctectomy and pouch with diverting ileostomy, finally stoma closure) a proctocolectomy is done and continuity can be restored with a ileoanal pouch (Sahami, Buskens, et al., 2016; Zittan et al., 2016). These are the preferred options for the majority of our patients. Alternatives are proctocolectomy with definitive end-ileostomy or a continent ileostomy.
Quality of life of patients with pouches depends predominantly on proper function of the pouch. Inadequate function and long term pouch failure are determined by the occurrence of chronic anastomotic leaks, chronic pouchitis and a delayed diagnosis of Crohn's disease in and around the pouch (Lightner et al., 2017). The latter two diagnoses, Crohn's disease and chronic pouchitis are in an important number in fact misdiagnosed chronic leaks (Garrett et al., 2009; van der Ploeg, Maeda, Faiz, Hart, & Clark, 2017). Long-term pouch failure rates (pouch excision or secondary diversion of the pouch) add up to more than 1 out of 10 at 10 years (Ikeuchi et al., 2018; Lightner et al., 2017; Mark-Christensen et al., 2018). These data represent the results of expert centers, so real life data are probably worse. Chronic leaks are late sequalae leaking anastomosis which has been inadequately treated; misdiagnosed or diagnosed too late to treat successfully.
Although many centers publish more favorable figures, the true rate of anastomotic leakage of ileoanal pouches probably varies from 10-20% (Sahami, Bartels, et al., 2016; Sossenheimer et al., 2019; Widmar et al., 2019). There is an important underreporting of the leaks. If the pouch is diverted, the leak will only become apparent prior to ileostomy closure when the anastomosis is tested. Even testing the anastomosis is not 100% accurate accounting for a number of misdiagnosed leaks. These misdiagnosed and delayed diagnosed leaks are generally not included in series reporting short term results (Santorelli, Hollingshead, & Clark, 2018; Sossenheimer et al., 2019; Widmar et al., 2019).
For all these reasons it is of great importance to prevent anastomotic leakage when creating a ileoanal pouch and if it happens, to solve the problem as soon as possible.
Numerous risk factors have been identified for anastomotic leakage. The most important factors are tension on the anastomosis, inadequate vascularization of the pouch, an unfavorable microbiome and the use of immunosuppressive drugs (steroids, immunomodulators, biologic treatments). By staging the restorative proctocolectomy, the negative impact of immunosuppressive drugs on anastomotic healing are avoided because at the time of the pouch creation the drugs are weaned for a long period. Other factors including anastomotic technique and anastomotic perfusion are modifiable surgical factors. A more recently described pathophysiological mechanism relates to the intestinal microbiome (Alverdy, Hyoju, Weigerinck, & Gilbert, 2017). Apparently, this holds true for small bowel surgery as well (Lesalnieks, Hoene, Bittermann, Schlitt, & Hackl, 2018).
Proper management of a leak comprises early diagnosis and immediate and adequate management. Sequential CRP measurement and early investigation of the integrity of the anastomosis are key for early diagnosis, particularly in a diverted anastomosis which might not be symptomatic (Adamina et al., 2015; Warschkow et al., 2012).
The current management of the leak usually involves a diverting ileostomy, if not performed primarily, in combination with passive drainage of the abscess cavity via transanal or transcutaneous route. This approach showed to be relatively ineffective leading to a pouch failure rate of 20%, and if resolved to a worse pouch function (Garrett et al., 2009; Lightner et al., 2017).
Endosponge vacuum assisted closure (EVAC) of the anastomotic leak on the contrary showed to have a very high success rate and to prevent long-term pouch dysfunction and failure (Bemelman & Baron, 2018; Gardenbroek et al., 2015; Verlaan et al., 2011; Weidenhagen, Gruetzner, Wiecken, Spelsberg, & Jauch, 2008).
There is minimal risk to patients as there is no introduction of a novel technique, rather this study is an amalgamation of published improvements in pouch surgery pre, intra and post-operatively to reduce the leak rate at one year.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ulcerative Colitis
Keywords
ileoanal pouch, IPAA, pouch, ulcerative colitis, leak
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
The MIRACLE study is an international multicenter clinical effectiveness study, whereby the current local practice (control cohort) will be evaluated, and subsequently compared to the results after implementation of the multi-interventional program (intervention cohort).
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Historic cohort
Arm Type
No Intervention
Arm Title
Multi-interventional program cohort
Arm Type
Other
Intervention Type
Procedure
Intervention Name(s)
Multi-interventional program
Intervention Description
Preoperative oral antibiotics and antibiotic enema of the rectal stump prior to the surgery
Routine and tailored lengthening measures of the mesentery
Intraoperative control of pouch vascularization using ICG
Early diagnosis and active assessment of the integrity of the anastomosis.
Routine CRP-measurements at day 4 and 6 (after removal pouch catheter) in the non-diverted pouches with CT-scan with rectal contrast if any suspicion on a leak (elevated or rise in CRP. symptoms).
Routine CRP-measurements at day 4 in the diverted pouches with endoscopy 10-14 days after pouch creation.
Endosponge vacuum assisted closure (EVAC) of the anastomotic defect aiming to close the defect within 10-14 days after diagnosis.
MRI assessment of the pouch after stoma closure preferably at one year to rule out chronic sepsis mimicking pouchitis or Crohn's disease.
Primary Outcome Measure Information:
Title
Leak rate
Description
Anastomotic integrity at one year postoperatively defined as the absence of presacral collections, anastomotic fistula and severe anastomotic stricture (not amenable for digital dilatation by rectal exam).
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Cumulative anastomotic dehiscence rate
Description
Anastomotic insufficiency at 30 days, 6 months and 12 months defined as contrast extravasation and/or presacral perianastomotic fluid collections on CT scan or Anastomotic dehiscence at endoscopy.
Time Frame
18 month
Title
QOL
Description
Quality of life and functional outcomes preoperatively and then 3, 6, 12 and 18 months post-operatively.
Time Frame
3,6,12 and 18 months
Title
Protocol compliance
Description
Protocol compliance to any intervention
Time Frame
18 month
Title
ICG
Description
Change in management due to ICG
Time Frame
Operative
Title
CRP
Description
Diagnostic accuracy of CRP for anastomotic leakage
Time Frame
30 days
Title
EVAC
Description
Efficacy of EVAC with early transanal closure of the anastomotic defect
Time Frame
18 month
Title
Stoma rate
Description
Permanent stoma rate at 18 months
Time Frame
18 month
Title
Temporary ileostomy rate and duration
Description
Temporary stoma rate and stoma duration at 18 months
Time Frame
18 month
Title
Complications
Description
Operative and post-operative complications within 30 days and 12 months (cumulative) of operation (using the Clavien-Dindo classification of surgical complications)
Time Frame
1 year
Title
Death
Description
Death
Time Frame
1 year
Title
Hospital stay
Description
Hospital stay and total hospital stay at one year
Time Frame
1 year
Title
Reintervention rate
Description
Reintervention rate
Time Frame
18 month
Title
Readmission
Description
Overall and stoma-related readmission
Time Frame
18 month
Title
Cost analysis of EVAC
Description
Cost analysis of anastomotic leakage and EVAC therapy
Time Frame
18 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosis of Ulcerative Colitis
Diagnosis of Crohn's disease limited to the colon without any history of perianal disease
Modified two or three stage restorative proctocolectomy
Age above 18
Able to fill in questionnaires in local language and to come to out-patient-clinic visits;
Exclusion Criteria:
Known allergy to ICG, or iodide allergy.
Pregnancy
Redo pouch operation
Age under 18
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mohammed Deputy
Phone
+447958395012
Email
m.deputy@nhs.net
12. IPD Sharing Statement
Learn more about this trial
Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC
We'll reach out to this number within 24 hrs